Disclosed herein is a method for producing human antibodies against a pathogen comprising injecting a non-human animal with a pathogen-derived DNA vaccine in at least two locations of the animal injecting the animal with an adjuvant in a location of the animal different from the location of the DNA vaccine location collecting plasma from the animal after the injections and purifying polyclonal antibody from the plasma.